Your session is about to expire
← Back to Search
Behavioural Intervention
Virtual Reality Treadmill Training for Traumatic Brain Injury
N/A
Recruiting
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Inclusion/
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 training sessions
Awards & highlights
No Placebo-Only Group
Summary
This trial evaluates the effectiveness of VR-based treadmill training on walking, cognition, and brain activity in individuals with brain injury.
Who is the study for?
This trial is for individuals with traumatic brain injury (TBI) who are able to walk or stand on a treadmill. It's also open to healthy people without TBI for comparison. Participants must be willing to undergo multiple training and data collection sessions, and use a safety harness during exercises.
What is being tested?
The study tests if virtual reality-based treadmill training improves walking in those with TBI. There are three groups: one using VR cues while walking, another just walking on the treadmill without cues, and a healthy control group for baseline comparisons.
What are the potential side effects?
There may not be direct side effects from the interventions since they involve physical training; however, there's always a risk of fatigue or muscle soreness from exercise, and falls despite safety measures like harnesses and spotters.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 training sessions
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 training sessions
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Cortical Activity
Change in Dynamic Gait Index (DGI)
Change in Montreal Cognitive Assessment Test
+7 moreSecondary study objectives
Change in C-MILL Force Data
Change in Continuous Performance Task (CPT)
Change in Electromyography
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: C-MILL training groupExperimental Treatment1 Intervention
The participants will be screened for the inclusion/exclusion criteria and consented during the first session. They will participate in two data collection sessions, one before the training and one after the training. The participants will undergo 10 training sessions. Individuals in the CTG will receive gait and balance training sessions with the virtual reality and auditory cues using C-MILL (such as walking on a pathway, obstacle avoidance, lateral balance etc.) to provide task specific training. C-Mill (Motekforce Link, Amsterdam, The Netherlands) is an instrumented treadmill that uses visual (on the screen as well on the treadmill) and acoustic cues for gait and balance training. The C-Mill allows for gait and balance adaptability strategy as it can provide obstacle avoidance environments, change in speed and various walking pathways in a safe and controlled environment.
Group II: Treadmill training group (TTG)Active Control1 Intervention
The participants will be screened for the inclusion/exclusion criteria and consented during the first session. They will participate in two data collection sessions, one before the training and one after the training. The participants will undergo 10 training sessions. Individuals in TTG group will walk on the treadmill (C-MILL) or stand on the treadmill (C-MILL) with no visual or auditory cues.
Group III: Healthy ControlActive Control1 Intervention
HCG will participate in up to four sessions. The participants will be screened for the inclusion/exclusion criteria and consented during the first session. They will participate in two data collection sessions and one C-MILL session.
Find a Location
Who is running the clinical trial?
Kessler FoundationLead Sponsor
181 Previous Clinical Trials
11,049 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger